These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 13496331
1. Reserpine, alone & combined with pentapyrrolidine bitartrate (ansolysen), in prolonged ambulatory therapy of arterial hypertension. FLACHS A, FRANTZEN A, ROJEL J. Ugeskr Laeger; 1957 Oct 03; 119(40):1306-10. PubMed ID: 13496331 [No Abstract] [Full Text] [Related]
2. [Decrease in blood pressure after parenteral trial doses of reserpine (serpasil), hydralazine (apresolin), and pentapyrrolidin (ansolysen) in patients with arterial hypertension, with special reference to the value of the test as an indicator of the clinical effect in subsequent peroral prolonged treatment]. KJERULF-JENSEN K, STURUP H. Ugeskr Laeger; 1956 Oct 04; 118(40):1166-7. PubMed ID: 13392090 [No Abstract] [Full Text] [Related]
6. Renal haemodynamic effects of hypotensive drugs. II. Effects of oral maintenance therapy with pentapyrrolidinium bitartrate and reserpine. GOLDBERG B, MCDONALD L. Lancet; 1957 Jan 12; 272(6959):77-8. PubMed ID: 13386279 [No Abstract] [Full Text] [Related]
12. [Clinical studies of a new hypotensive drug in tuberculosis patients]. RAMPINI GF. Gazz Med Ital; 1959 Jan 12; 118(1):32-6. PubMed ID: 13653336 [No Abstract] [Full Text] [Related]
13. Treatment of hypertension in out patients; the effect of pentolinium. FIFE R, PATON JP, WHYTE WG. Scott Med J; 1959 May 12; 4(5):242-8. PubMed ID: 13668576 [No Abstract] [Full Text] [Related]
19. Effect of hypotensive drugs on renal function in chronic renal disease. ABRAHAMS DG, WILSON C. Lancet; 1957 Jan 12; 272(6959):68-74. PubMed ID: 13386277 [No Abstract] [Full Text] [Related]